PT2404593T - Composition containing quaternary ammonium compounds - Google Patents
Composition containing quaternary ammonium compoundsInfo
- Publication number
- PT2404593T PT2404593T PT111650115T PT11165011T PT2404593T PT 2404593 T PT2404593 T PT 2404593T PT 111650115 T PT111650115 T PT 111650115T PT 11165011 T PT11165011 T PT 11165011T PT 2404593 T PT2404593 T PT 2404593T
- Authority
- PT
- Portugal
- Prior art keywords
- composition containing
- quaternary ammonium
- ammonium compounds
- containing quaternary
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/143—Quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/62—Quaternary ammonium compounds
- C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/494,493 US20080026013A1 (en) | 2006-07-28 | 2006-07-28 | Compositions containing quaternary ammonium compounds |
| EP06291236.5A EP1891939B1 (en) | 2006-07-28 | 2006-07-28 | Compositions containing quaternary ammonium compounds |
| EP07112097 | 2007-07-09 | ||
| PCT/IB2007/053441 WO2008035246A2 (en) | 2006-07-28 | 2007-07-10 | Compositions containing quaternary ammonium compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2404593T true PT2404593T (en) | 2016-08-16 |
Family
ID=65014357
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT111650115T PT2404593T (en) | 2006-07-28 | 2007-07-27 | Composition containing quaternary ammonium compounds |
| PT77879989T PT2049079T (en) | 2006-07-28 | 2007-07-27 | Compositions containing quaternary ammonium compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT77879989T PT2049079T (en) | 2006-07-28 | 2007-07-27 | Compositions containing quaternary ammonium compounds |
Country Status (18)
| Country | Link |
|---|---|
| US (7) | US7973081B2 (en) |
| EP (2) | EP2404593B1 (en) |
| JP (1) | JP5441058B2 (en) |
| KR (2) | KR101507097B1 (en) |
| AU (1) | AU2007278141B2 (en) |
| CA (1) | CA2659322C (en) |
| CY (3) | CY1118148T1 (en) |
| DK (2) | DK2404593T3 (en) |
| ES (2) | ES2606467T3 (en) |
| HK (1) | HK1165993A1 (en) |
| HU (2) | HUE030841T2 (en) |
| IL (2) | IL196740A (en) |
| LT (2) | LT2049079T (en) |
| LU (1) | LUC00006I2 (en) |
| PL (2) | PL2049079T3 (en) |
| PT (2) | PT2404593T (en) |
| SI (2) | SI2404593T1 (en) |
| WO (2) | WO2008035246A2 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2916636B1 (en) * | 2007-05-29 | 2009-09-04 | Octalia Technologies | VEHICLE IN THE FORM OF AN OIL-IN-WATER EMULSION PARTICULARLY FOR OPHTHALMIC OR DERMOCOSMETIC USE |
| JP2011521957A (en) * | 2008-05-28 | 2011-07-28 | アルコン リサーチ， リミテッド | Self-preserving emulsion |
| EP2228058A1 (en) | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Anionic oil-in-water emulsion containing prostaglandins and uses thereof |
| EP2228057A1 (en) * | 2009-03-04 | 2010-09-15 | Novagali Pharma S.A. | Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| US8388991B2 (en) | 2009-05-01 | 2013-03-05 | Chattem, Inc. | Moisturizing antimicrobial composition |
| CA2764802A1 (en) | 2009-06-05 | 2010-12-09 | Allergan, Inc. | Artificial tears and therapeutic uses |
| EP2389939A1 (en) | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
| WO2013098841A1 (en) * | 2011-10-31 | 2013-07-04 | Fdc Limited | Nanodispersion of poorly water soluble drug(s) |
| KR102017922B1 (en) * | 2011-12-07 | 2019-09-03 | 알러간, 인코포레이티드 | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
| EP2664329A1 (en) * | 2012-05-15 | 2013-11-20 | F. Holzer GmbH | Ophthalmological vehicle system |
| WO2015168140A1 (en) * | 2014-04-28 | 2015-11-05 | Hampton Technologies | Ophthalmic compositions and methods for treating eyes |
| US20160074178A1 (en) * | 2014-09-17 | 2016-03-17 | Van Phillips | METHODS FOR PREPARING PRECISELY FITTED CASTS for PROSTHETICS |
| EP3011959A1 (en) * | 2014-10-23 | 2016-04-27 | Santen SAS | Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha |
| MX2017006474A (en) | 2014-11-25 | 2017-09-12 | Allergan Inc | Stabilized omega-3 ophthalmic compositions. |
| US11324800B2 (en) | 2015-01-15 | 2022-05-10 | Wellspring Ophthalmics, Inc. | Aqueous suspensions of cyclosporin |
| US20200237859A1 (en) | 2019-01-25 | 2020-07-30 | Newport Research, Inc. | Aqueous suspensions of cyclosporin |
| DK3266446T3 (en) * | 2016-07-07 | 2019-02-11 | Salvat Lab Sa | Eye preparation comprising castor oil and medium chain triglyceride |
| EP3970692A1 (en) * | 2020-09-18 | 2022-03-23 | Omnivision GmbH | Lipid-based ophthalmic composition for the treatment of dry eye |
| CN116390762A (en) | 2020-11-09 | 2023-07-04 | 思凯制药有限公司 | Solid cyclosporin A and dispersion composition containing the same |
| US11471475B1 (en) * | 2022-03-08 | 2022-10-18 | Ralph P. Stone | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery |
| WO2024069490A1 (en) * | 2022-09-28 | 2024-04-04 | Polaroid Ip B.V. | Antimicrobial coating compositions |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB633175A (en) * | 1946-09-03 | 1949-12-12 | Parke Davis & Co | Antibiotic preparations and process for obtaining the same |
| USB724600I5 (en) * | 1968-04-26 | |||
| AU499860B2 (en) | 1975-04-24 | 1979-05-03 | Honda Giken Kogyo Kabushiki Kaisha | Deflector plate to equalise fuel distribution in induction gas flow |
| US5188826A (en) | 1988-02-08 | 1993-02-23 | Insite Vision Incorporated | Topical ophthalmic suspensions |
| FR2648462B1 (en) * | 1989-06-15 | 1994-01-28 | Oreal | PROCESS FOR IMPROVING THE THERAPEUTIC EFFICIENCY OF LIPOSOLUBLE CORTICOSTEROIDS AND COMPOSITION FOR CARRYING OUT SAID METHOD |
| JPH05116286A (en) | 1991-10-25 | 1993-05-14 | Matsushita Electric Ind Co Ltd | Ink discharge device |
| IL101241A (en) | 1992-03-16 | 1997-11-20 | Yissum Res Dev Co | Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier |
| IL103907A0 (en) * | 1992-11-27 | 1993-04-04 | Pharmos Corp | Ophthalmic compositions |
| SG49746A1 (en) | 1992-08-28 | 1998-06-15 | Pharmos Corp | Submicron emulsions as ocular drug delivery vehicles |
| US5951988A (en) * | 1993-03-30 | 1999-09-14 | University Of Saskatchewan | Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods |
| DE69411816T2 (en) | 1993-06-25 | 1998-12-03 | Alcon Cusi S A | New use of polymeric membranes for dispensing pharmaceutical solutions containing quaternary ammonium compounds used as preservatives and corresponding dosing containers |
| CA2131037A1 (en) * | 1993-08-30 | 1995-03-01 | Judy B. Chung | Shampoo-conditioner composition |
| AU2593695A (en) * | 1994-05-20 | 1995-12-18 | Novavax, Inc. | Antibacterial oil-in-water emulsions |
| US5547990A (en) * | 1994-05-20 | 1996-08-20 | Lonza, Inc. | Disinfectants and sanitizers with reduced eye irritation potential |
| US5435998A (en) * | 1994-08-03 | 1995-07-25 | Abelson; Mark B. | Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents |
| ES2094688B1 (en) | 1994-08-08 | 1997-08-01 | Cusi Lab | MANOEMULSION OF THE TYPE OF OIL IN WATER, USEFUL AS AN OPHTHALMIC VEHICLE AND PROCEDURE FOR ITS PREPARATION. |
| US5767153A (en) | 1995-06-07 | 1998-06-16 | Insite Vision Incorporated | Sustained release emulsions |
| TW446563B (en) * | 1996-01-16 | 2001-07-21 | Colgate Palmolive Co | Low static conditioning shampoo |
| US6071904A (en) * | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
| US6114319A (en) | 1997-05-14 | 2000-09-05 | Senju Pharmaceutical Co., Ltd. | Compositions containing difluprednate |
| US20020169138A1 (en) * | 1997-10-24 | 2002-11-14 | Southern Research Institute | Delivery vehicles for bioactive agents and uses thereof |
| AU3548499A (en) | 1998-04-02 | 1999-10-25 | Schepens Eye Research Institute, Inc., The | Corneal organ culture system for chemical toxicity tests of consumer products |
| FR2780879B1 (en) * | 1998-07-09 | 2002-09-20 | Oreal | PHOTOPROTECTOR COSMETIC COMPOSITION CONTAINING AN ANIONIC SURFACTANT, COMPOUND FILTERING ULTRAVIOLET RADIATION AND CATIONIC OR ZPHITTERIONIC AMPHIPHILIC COMPOUND AND USE THEREOF |
| AU761785B2 (en) * | 1998-09-25 | 2003-06-12 | Alcon Laboratories, Inc. | Sustained release, and comfortable ophthalmic composition and method for ocular therapy |
| US6030789A (en) | 1999-03-10 | 2000-02-29 | The Gillette Company | Human conjunctival epithelial cell lines with an extended life span |
| US6635676B2 (en) | 1999-04-28 | 2003-10-21 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
| TR200200737T2 (en) | 1999-09-24 | 2002-08-21 | Alcon, Inc. | Local suspension formulations containing ciproflaxacin and dexamethasone |
| PT1142566E (en) | 2000-04-07 | 2004-02-27 | Medidom Lab | Topical Formulin Formulation in the Form of a Aqueous Solution and Use of a Cyclosporine in Association with Hyaluronic Acid or One of Its Salts and with Polysorbate 80 |
| US20030017181A1 (en) * | 2001-05-31 | 2003-01-23 | Rood Gloria A. | Dermatological compositions and methods |
| US7314624B2 (en) | 2001-06-05 | 2008-01-01 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
| US6872705B2 (en) | 2001-07-13 | 2005-03-29 | Allergan, Inc. | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions |
| US6656460B2 (en) * | 2001-11-01 | 2003-12-02 | Yissum Research Development | Method and composition for dry eye treatment |
| ES2343512T3 (en) | 2001-11-01 | 2010-08-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | PROCEDURE AND COMPOSITION FOR DRY EYE TREATMENT. |
| US20030165545A1 (en) | 2002-01-30 | 2003-09-04 | Allergan, Inc. | Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same |
| ATE343376T1 (en) | 2002-03-20 | 2006-11-15 | Elan Pharma Int Ltd | NANOPARTICLE COMPOSITIONS OF ANGIOGENESIS INHIBITORS |
| US20050059583A1 (en) | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
| JP5382972B2 (en) | 2003-12-26 | 2014-01-08 | ロート製薬株式会社 | Composition with reduced viscosity prevention |
| US20050175651A1 (en) | 2004-01-09 | 2005-08-11 | L'oreal | Aqueous dispersion of nanocapsules with an oily core |
| US20050158349A1 (en) | 2004-01-20 | 2005-07-21 | Jampani Hanuman B. | Two-phase compositions containing alcohol |
| ATE439123T1 (en) | 2004-07-02 | 2009-08-15 | Novagali Pharma Sa | USE OF EMULSIONS FOR INTRA- AND PERIOCULAR INJECTION |
| DE602004017477D1 (en) | 2004-11-09 | 2008-12-11 | Novagali Pharma Sa | Oil-in-water emulsion with low concentration of cationic agent and positive zeta potential |
| CA2578176C (en) * | 2004-11-09 | 2013-09-24 | Novagali Pharma Sa | Ophthalmic emulsions containing an immunosuppressive agent |
| JP2009525284A (en) | 2006-01-30 | 2009-07-09 | タイタン ファーマシューティカルズ インコーポレイテッド | Use of gallium to treat biofilm-related infections |
| US20080026013A1 (en) * | 2006-07-28 | 2008-01-31 | Laura Rabinovich-Guilatt | Compositions containing quaternary ammonium compounds |
| US20090018057A1 (en) * | 2007-07-09 | 2009-01-15 | Gregory Lambert | OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
-
2007
- 2007-07-10 WO PCT/IB2007/053441 patent/WO2008035246A2/en active Application Filing
- 2007-07-27 PT PT111650115T patent/PT2404593T/en unknown
- 2007-07-27 US US11/829,428 patent/US7973081B2/en active Active
- 2007-07-27 SI SI200731814A patent/SI2404593T1/en unknown
- 2007-07-27 WO PCT/EP2007/057784 patent/WO2008012367A2/en active Application Filing
- 2007-07-27 DK DK11165011.5T patent/DK2404593T3/en active
- 2007-07-27 PL PL07787998T patent/PL2049079T3/en unknown
- 2007-07-27 DK DK07787998.9T patent/DK2049079T3/en active
- 2007-07-27 HU HUE07787998A patent/HUE030841T2/en unknown
- 2007-07-27 LT LTEP07787998.9T patent/LT2049079T/en unknown
- 2007-07-27 HU HUE11165011A patent/HUE029987T2/en unknown
- 2007-07-27 AU AU2007278141A patent/AU2007278141B2/en active Active
- 2007-07-27 PT PT77879989T patent/PT2049079T/en unknown
- 2007-07-27 KR KR1020147003945A patent/KR101507097B1/en active IP Right Grant
- 2007-07-27 EP EP11165011.5A patent/EP2404593B1/en active Active
- 2007-07-27 KR KR1020097004115A patent/KR101507465B1/en active IP Right Grant
- 2007-07-27 ES ES07787998.9T patent/ES2606467T3/en active Active
- 2007-07-27 CA CA2659322A patent/CA2659322C/en active Active
- 2007-07-27 EP EP07787998.9A patent/EP2049079B1/en active Active
- 2007-07-27 ES ES11165011.5T patent/ES2586381T3/en active Active
- 2007-07-27 SI SI200731866A patent/SI2049079T1/en unknown
- 2007-07-27 PL PL11165011.5T patent/PL2404593T3/en unknown
- 2007-07-27 JP JP2009521280A patent/JP5441058B2/en active Active
-
2009
- 2009-01-27 IL IL196740A patent/IL196740A/en active IP Right Grant
-
2011
- 2011-04-28 US US13/096,512 patent/US8524779B2/en active Active
-
2012
- 2012-07-06 HK HK12106653.1A patent/HK1165993A1/en unknown
-
2013
- 2013-08-02 US US13/957,621 patent/US9220694B2/en active Active
-
2015
- 2015-09-21 IL IL241753A patent/IL241753B/en active IP Right Grant
- 2015-11-17 US US14/943,649 patent/US9956289B2/en active Active
-
2016
- 2016-08-05 CY CY20161100773T patent/CY1118148T1/en unknown
- 2016-12-02 CY CY20161101244T patent/CY1118436T1/en unknown
-
2017
- 2017-02-15 LT LTPA2017003C patent/LTC2049079I2/en unknown
- 2017-02-22 CY CY2017007C patent/CY2017007I2/en unknown
- 2017-02-23 LU LU00006C patent/LUC00006I2/en unknown
-
2018
- 2018-04-05 US US15/946,325 patent/US10842873B2/en active Active
-
2020
- 2020-10-21 US US16/949,237 patent/US11612658B2/en active Active
-
2023
- 2023-02-10 US US18/167,125 patent/US20230181738A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241753B (en) | Compositions containing quaternary ammonium compounds | |
| HUS1700007I1 (en) | Compositions containing quaternary ammonium compounds | |
| HUS1900033I1 (en) | Substituted enaminocarbonyl compounds | |
| IL185312A0 (en) | Compositions containing aptamers | |
| GB0602424D0 (en) | Compounds | |
| GB0602046D0 (en) | Compounds | |
| IL190321A0 (en) | Compositions containing saratin | |
| EP1984379A4 (en) | Anti-arenaviral compounds | |
| GB2436469B (en) | Quaternary ammonium compounds and their uses | |
| HK1112409A1 (en) | Compositions containing quaternary ammonium compounds | |
| PL2190800T3 (en) | Mixture containing quaternary ammonium compound and its use | |
| EP2082022A4 (en) | Compounds | |
| EP2004174A4 (en) | Naphthalenedione compounds | |
| GB0602042D0 (en) | Compounds | |
| SG10201601998PA (en) | Compositions containing lignan-class compounds | |
| EP1973905A4 (en) | Compounds | |
| ZA200901570B (en) | Substituted azolin-2-YL-amino compounds | |
| EP2016069A4 (en) | Bis-pyridinium compounds | |
| GB0602412D0 (en) | Compounds | |
| GB0600427D0 (en) | Compounds | |
| GB0602040D0 (en) | Compounds | |
| GB0602134D0 (en) | Compounds | |
| GB0601505D0 (en) | Compounds | |
| GB0600929D0 (en) | Compounds | |
| GB0600426D0 (en) | Compounds |